SESSION IX SCHEDULE
Thursday
SESSION IX: TOPICS OF INTEREST TO INTERVENTIONALISTS, CARDIAC SURGEONS AND VASCULAR SURGEONS (APPROACHES, PERCUTANEOUS VALVES, THORACIC ENDOGRAFTS) (7-MINUTE TALKS)
Moderators:Roy K. Greenberg, M.D. / Frank J. Veith, M.D.
x
6:40 AM - 6:47 AM Open Aortic Valve Repair: What Are The Challenges For An Endovascular Approach (Video Presentation)
  Presenters: Tomislav Mihaljevic, M.D.  
6:48 AM - 6:55 AM Strategies For Endovascular Aortic Valve Repair: Balloon Expandable And Self-Expanding; Transfemoral And Trans-Apical
  Presenters: Martin B. Leon, M.D.  
6:56 AM - 7:03 AM Strategies For Endovascular Mitral Valve Repair: Leaflet Approximation Versus Annuloplasty
  Presenters: Ted Feldman, M.D.  
7:04 AM - 7:11 AM Complications Of Endovascular Valve Repair: Lessons Learned From Early Experience
  Presenters: Michael J. Mack, M.D.  
7:12 AM - 7:19 AM Anatomic Factors Predictive Of Thoracic Aortic Endograft Collapse As Determined By Ciné MRA: When Will Endografting Be Possible And Not Possible In This High Flow Environment?
  Presenters: Bart E. Muhs, M.D., Ph.D. / Hence J.M. Verhagen, M.D., Ph.D.  
7:20 AM - 7:27 AM Use Of PFO Closure Devices And Endografts For Endovascular Repair Of Ascending Aortic And Arch Aneurysms
  Presenters: Edward B. Diethrich, M.D.  
7:28 AM - 7:35 AM Endograft Repair Of Thoracic Aortic Lesions Close To The Arch Is Still A Challenge
  Presenters: Jean-Pierre Becquemin, M.D., F.R.C.S.  
7:36 AM - 7:43 AM Thoracic Endografting: What Problems Have Been Solved; What Are We Solving; And What Challenges Remain
  Presenters: Michael D. Dake, M.D.  
7:44 AM - 7:51 AM Panel Discussion
END OF SESSION IX
 
SESSION X SCHEDULE
Thursday
SESSION X: MORE TOPICS FOR INTERVENTIONISTS, CARDIAC SURGEONS AND VASCULAR SURGEONS ABOUT THORACIC ENDOGRAFTING (6-MINUTE FAST PACED TALKS)
Moderators:Bruce Lytle, M.D. / Frank J. Veith, M.D.
x
7:51 AM - 7:57 AM Debate: Hybrid Approaches To Thoracic Aortic Aneurysms (TAAs) Involving Arch Vessels: Extra-Anatomic Bypass Is Less Invasive And Best
  Presenters: Alan B. Lumsden, M.D., F.A.C.S.  
7:58 AM - 8:04 AM Debate: Direct Approach To TAAs Involving The Arch Vessels By The Elephant Trunk (Hybrid Technique) Is Best And More Durable
  Presenters: Lars G. Svensson, M.D., Ph.D  
8:05 AM - 8:11 AM Debate: Treatment Of Thoracoabdominal AAAs Will Be Most Effective If Accomplished With Fenestrated Grafts And Stent-Graft Branches
  Presenters: Roy K. Greenberg, M.D.  
8:12 AM - 8:18 AM Debate: Treatment Of TAAAs Will Be Most Effective If Accomplished With A Branched Main Body And Stent-Graft Extensions
  Presenters: Timothy A.M. Chuter, M.D.  
8:19 AM - 8:25 AM The INSTEAD Trial Update: What Is The Role Of Endografting Versus Medical Management In Uncomplicated Type B Dissections And What Factors Are Predictive Of A Dire Outcome And Justify Early Stent-Grafting?
  Presenters: Christoph A. Nienaber, M.D., Ph.D.  
8:26 AM - 8:32 AM Results With The Cook Zenith Dissection Device Featuring Covered And Uncovered Stent Portions For Treatment Of Type B Dissections
  Presenters: Joseph V. Lombardi, M.D.  
8:33 AM - 8:39 AM Fenestrated And Branched Stent-Grafts For Diffuse Aortic Arch Lesions: Techniques, Problems And Results
  Presenters: Krassi Ivancev, M.D., Ph.D.  
8:40 AM - 8:46 AM Long-Term (5-Year) Trial Results Of TAA Repair With The Gore TAG Endograft: Up To 45 mm In Diameter
  Presenters: Michel S. Makaroun, M.D.  
8:47 AM - 8:53 AM Updated Trial Results With The Cook Zenith TX 2 Endograft For Thoracic Aortic Pathology
  Presenters: Jon S. Matsumura, M.D.  
8:54 AM - 9:00 AM Results Of The VALOR Trial For Treatment Of Thoracic Aortic Lesions: Pivotal And High Risk Arms And VALOR II Design
  Presenters: Ronald M. Fairman, M.D.  
9:00 AM - 9:12 AM Panel Discussion
END OF SESSION X
 
SESSION XI SCHEDULE
Thursday
SESSION XI: NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC AORTIC PATHOLOGY: NEWER STENT-GRAFTS, MODIFICATIONS AND COMPLICATIONS (6-MINUTE TALKS)
Moderators:Christoph A. Nienaber, M.D., Ph.D. / Frank J. Veith, M.D.
x
9:12 AM - 9:18 AM Durability Of Branched And Fenestrated Grafts: How Long Can They Last: Are They Ready For Use In Good Risk Patients?
  Presenters: John L. Anderson, M.D.  
9:19 AM - 9:25 AM Advantages And Current Limitations Of Endograft Treatment Of Acute Traumatic Disruption Of The Aorta: Needs For The Future And Challenges For Current Thoracic Graft Designs
  Presenters: Mark A. Farber, M.D.  
9:26 AM - 9:32 AM Update On The Bolton Relay Graft For Thoracic Aortic Pathology: What Are Its Advantages And Limitations?
  Presenters: Vicente Riambau, M.D., Ph.D.  
9:33 AM - 9:39 AM Results Of Gore TAG Device For Complex Thoracic Pathology: Ruptured TAAs And Complicated Type B Dissections: A Multicenter Study
  Presenters: Richard P. Cambria, M.D. / Christopher J. Kwolek, M.D.  
9:40 AM - 9:46 AM Are Current Thoracic Aortic Grafts The Answer: Do We Need A Better Graft And Will It Be Available? The VI Thoracic Graft
  Presenters: Juan C. Parodi, M.D.  
9:47 AM - 9:53 AM Ten-Year Experience With TEVAR: It Is Not All Perfect
  Presenters: Gioacchino Coppi, M.D.  
9:54 AM - 10:00 AM Treatment Of Coarctation Of The Aorta With Covered Balloon Expandable Stents
  Presenters: Elchanan Bruckheimer, M.B.B.S.  
10:00 AM - 10:07 AM Techniques For Dealing With Short Bad Necks In Urgent Pararenal Aneurysms: Surgeon Modified Fenestrated Grafts And Chimney Stent-Grafts: Techniques Of Preparation And Results
  Presenters: Krassi Ivancev, M.D., Ph.D. / Martin Malina, M.D., Ph.D. / Timothy A. Resch, M.D., Ph.D.  
10:08 AM - 10:18 AM Panel Discussion
END OF SESSION XI
 
SESSION XII SCHEDULE
Thursday
SESSION XII: NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENTS: THE STATE-OF-THE-ART AND NEW ADJUNCTS (6-MINUTE TALKS)
Moderators:Enrico Ascher, M.D. / Götz M. Richter, M.D., Ph.D.
x
10:18 AM - 10:24 AM Biomechanical Bases For Treatment Of SFA Disease: Factors Involving Stents And The Artery: Can They Be Resolved And How To Design The Perfect Stent For The SFA
  Presenters: Daniel Y. Sze, M.D., Ph.D.  
10:25 AM - 10:31 AM Debate: Late Results With The Silverhawk Device: Rotational Atherectomy For Infrainguinal Arteriosclerosis Is A Good Thing
  Presenters: Venkatesh G. Ramaiah, M.D.  
10:32 AM - 10:38 AM Debate: Durability Of Treatment With The Silverhawk Atherectomy Device: Why It Has Limited Value
  Presenters: Timur P. Sarac, M.D.  
10:39 AM - 10:45 AM Present And Future Of Endovascular SFA Treatment: Stents, Stent-Grafts, Drug Coated Balloons And Drug Coated Stents: What’s On The Horizon?
  Presenters: Marc Bosiers, M.D.  
10:46 AM - 10:52 AM New Concepts In Atherectomy Devices And Stents And Their Role In Tibial Artery Disease: Will Drug Eluting Stents Help?
  Presenters: Dierk Scheinert, M.D.  
10:53 AM - 10:59 AM How Good Are Present Stents In The SFA And Popliteal Arteries: Will Bioabsorbable Stents Or New Lasers (Turbobooster) Help?
  Presenters: Giancarlo Biamino, M.D.  
11:00 AM - 11:06 AM Limits Of Endovascular Treatment Of Femoropopliteal Occlusive Disease: Gender, Diabetes, Calcification And Aneurysmal Disease Make A Difference: What Is The Need For Embolic Protection?
  Presenters: Klaus D. Hagspiel, M.D.  
11:07 AM - 11:13 AM Late Results (3-5 Years) With Zilver Plain Nitinol Stents For TASC C & D SFA Lesions
  Presenters: Marcelo Ferreira, M.D.  
11:14 AM - 11:20 AM Will Drug Eluting Stents Do Better In The SFA: Results With The Cook Zilver PTX Drug Coated Stent Without A Polymer
  Presenters: Michael D. Dake, M.D.  
11:21 AM - 11:27 AM Results With The Edwards Life Stent For Femoropopliteal Occlusive Disease: Does The Stent Make A Difference In This Difficult Location: The RESILIENT Trial Results
  Presenters: Barry T. Katzen, M.D.  
11:28 AM - 11:35 AM Panel Discussion
END OF SESSION XII
 
SESSION XIII SCHEDULE
Thursday
SESSION XIII: NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE FAST PACED TALKS)
Moderators:Michael D. Dake, M.D. / Edward B. Diethrich, M.D.
x
11:35 AM - 11:40 AM Debate: Fenestrated Grafts Are Necessary In A Substantial Percentage Of AAA Patients
  Presenters: Eric L.G. Verhoeven, M.D., Ph.D.  
11:41 AM - 11:46 AM Debate: Fenestrated Grafts Are Used Too Often And Are Only Necessary In A Small Percentage Of AAA Patients
  Presenters: Jacob Buth, M.D.  
11:47 AM - 11:52 AM Branched Grafts To Preserve Hypogastric Arteries
  Presenters: John L. Anderson, M.D.  
11:53 AM - 11:58 AM Safety Of Bilateral Hypogastric Artery Interruption When Necessary
  Presenters: Manish Mehta, M.D., M.P.H. / Frank J. Veith, M.D.  
11:59 AM - 12:04 PM Debate: The Role Of Open Surgery For TAAs And TAAAs Will Be Substantial In The Endovascular Era: Open Surgery Is Still The Gold Standard
  Presenters: Hazim J. Safi, M.D.  
12:05 PM - 12:10 PM Debate: The Role Of Open Surgery In The Endovascular Era Will Be Minimal
  Presenters: Timothy A.M. Chuter, M.D.  
12:11 PM - 12:16 PM Who Should Be Treating Thoracic And Thoracoabdominal Aneurysms For The Patient’s Sake: Who, When, How And Where?
  Presenters: Michael J. Jacobs, M.D.  
12:17 PM - 12:22 PM A New Endograft For Total Aortic Arch Replacement
  Presenters: Syde A. Taheri, M.D.  
12:23 PM - 12:28 PM Influence Of Stent Type On Hemodynamic Changes (Depression) After CAS
  Presenters: Barry T. Katzen, M.D.  
12:29 PM - 12:39 PM Panel Discussion
12:40 PM - 1:30 PM Luncheon Break
END OF SESSION XIII
 
SESSION XIV SCHEDULE
Thursday
SESSION XIV: CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) (6-MINUTE TALKS)
Moderators:Peter Gaines, M.D. / Frank J. Veith, M.D.
x
1:30 PM - 1:36 PM CAS vs. CEA vs. Medical Treatment: How To Choose Without Bias
  Presenters: Michael R. Jaff, D.O.  
1:37 PM - 1:43 PM How To Pick By Duplex Ultrasonography Asymptomatic Patients Who Will Develop Symptoms And Who Need Treatment
  Presenters: Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS  
1:44 PM - 1:50 PM Carotid Plaque Characteristics And Their Therapeutic And Prognostic Implications
  Presenters: Giorgio M. Biasi, M.D.  
1:51 PM - 1:57 PM CAS Is Emerging As Best And Safest When Carotid Intervention May Not Be Needed At All: Is CEA Now Best After All And Will This Change With Better Devices?
  Presenters: Frank J. Criado, M.D.  
1:58 PM - 2:04 PM Are Statins Indicated Before CEA: How Long Before Should They Be Started?
  Presenters: Bruce A. Perler, M.D., M.B.A.  
2:05 PM - 2:11 PM Statins Prevent Strokes: The SPARCLE Trial: Does It Render NASCET, ECST, ACAS, ACST Obsolete And Mandate New Trials Of Best Medical Treatment Versus CEA And CAS?
  Presenters: Henrik Sillesen, MD, DMSc  
2:12 PM - 2:18 PM What Lesion Characteristics Are Associated With Increased Risk Of Stroke With CAS: Long Lesions Are Dangerous
  Presenters: Michel S. Makaroun, M.D. / Mark H. Wholey, M.D.  
2:19 PM - 2:25 PM CAS Can Be Done Without Cerebral Embolic Protection: How Can This Be Done Safely?
  Presenters: Franco Perona, M.D.  
2:26 PM - 2:32 PM Strategies For Avoiding Embolic And Non-Embolic Stroke With CAS: How To Choose An Embolic Protection Device
  Presenters: Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD  
2:33 PM - 2:40 PM Panel Discussion
Moderator(s): Jean-Pierre Becquemin, M.D., F.R.C.S. / Keith D. Calligaro, M.D.  
2:40 PM - 2:46 PM Debate: CAS Is Currently Being Underutilized Viz A Viz Medical Treatment And CEA: Reflections On CAS By A Master Who Has Done More Than 1,000
  Presenters: Mark H. Wholey, M.D.  
2:47 PM - 2:53 PM Debate: CAS Is Currently Being Overutilized Viz A Viz Medical Treatment And CEA
  Presenters: Peter R.F. Bell, M.D., F.R.C.S., D.S.C., K.B.E.  
2:54 PM - 3:00 PM Update On The German SPACE Trial: One Year Outcome Results With Subgroup Analysis: CEA vs. CAS In Symptomatic Patients
  Presenters: Hans-Henning Eckstein, M.D., Ph.D.  
3:01 PM - 3:07 PM The EVA-3S Trial Was Flawed Because The Interventionists Were Inexperienced And Not Representative Of The Best: One Participant’s View
  Presenters: Max Amor, M.D.  
3:08 PM - 3:14 PM The EVA-3S Trial Was Not Flawed Because The Interventionists Were State-Of-The-Art And Got Better Outcomes In Symptomatic Patients Than In The CAPTURE Trial: What Conclusion Should We Reach: The View Of Other Participants
  Presenters: Jean Michel Bartoli, M.D. / Philippe Piquet, M.D.  
3:15 PM - 3:21 PM Most Strokes Following CAS Occur After Embolic Protection Is Over: EVA-3S Was Not Flawed: Another Participant’s View
  Presenters: Emmanuel M. Houdart, M.D.  
3:22 PM - 3:28 PM Do We Need A Trial Comparing Current Best Medical Therapy Against CEA And CAS: What Is The Status Of The TACIT Trial: Will It Ever Happen?
  Presenters: John H. Rundback, M.D., F.S.I.R., F.A.H.A.  
3:29 PM - 3:38 PM Panel Discussion
END OF SESSION XIV
 
SESSION XV SCHEDULE
Thursday
SESSION XV: NEW DEVELOPMENTS OF INTEREST TO INTERVENTIONISTS AND VASCULAR SURGEONS: STENT-GRAFTS IN THE SFA AND OTHER NEW METHODS (6-MINUTE TALKS)
Moderators:Mark H. Wholey, M.D. / Alan Dardik, M.D., Ph.D.
x
3:38 PM - 3:44 PM Is There Still A Role For Open Surgery For Fem-Pop-Tibial Disease?
  Presenters: Enrico Ascher, M.D.  
3:45 PM - 3:51 PM 10-Year Experience With Viabahn Covered Stents For Long Femoropopliteal Occlusions: Technique, Results And Limitations
  Presenters: Jacques Bleyn, M.D.  
3:52 PM - 3:58 PM Use Of The Viabahn Stent-Graft For Chronic Total SFA Occlusions: A Note Of Caution
  Presenters: W. Anthony Lee, M.D.  
3:59 PM - 4:05 PM Role Of Stent-Grafts And Stents For SFA Occlusive Disease: Which Is Better And Under What Circumstances: Results Of The VIBRANT Trial Comparing Viabahn With Bare Metal Nitinol Stents
  Presenters: Mark W. Mewissen, M.D.  
4:06 PM - 4:12 PM The SAFARI Technique For Subintimal Angioplasty Of Tibial Vessels Employing A Distal Puncture Site
  Presenters: Klaus D. Hagspiel, M.D.  
4:13 PM - 4:19 PM Late Results After Viabahn Repair Of Popliteal Aneurysms
  Presenters: Jose Luis C. Nascimento Silva, M.D.  
4:20 PM - 4:26 PM 9-Month Clinical Results With A Biologically Covered Stent-Graft For Treating SFA Occlusions
  Presenters: Albrecht H. Krämer, M.D. / Timur P. Sarac, M.D. / Pierre Galvani Silveira, M.D.  
4:27 PM - 4:35 PM Panel Discussion
END OF SESSION XV
 
SESSION XVI SCHEDULE
Thursday
SESSION XVI: PREVENTION AND MANAGEMENT OF COMPLICATIONS (7-MINUTE TALKS)
Moderators:Kim J. Hodgson, M.D. / Michael B. Silva, Jr., M.D.
x
4:35 PM - 4:42 PM Complications Of Closure Devices: Tips And Tricks To Avoid Them And How To Manage Them
  Presenters: Jos C. van den Berg, M.D., Ph.D.  
4:43 PM - 4:50 PM Incidence And Importance Of Hypotension And Bradycardia With CAS: How To Predict And Manage Them
  Presenters: Peter H. Lin, M.D.  
4:51 PM - 4:58 PM For CAS Which Stent, Which Protection System Should We Use And Why: Which Lesion Should We Not Treat?
  Presenters: Marc Bosiers, M.D.  
4:59 PM - 5:06 PM How To Make CAS Safer
  Presenters: Emmanuel M. Houdart, M.D.  
5:07 PM - 5:14 PM Do Statins Reduce Myocardial Ischemia And Infarctions During Vascular Procedures: Why Must All Patients Be On Them Beforehand?
  Presenters: Don Poldermans, M.D.  
5:15 PM - 5:22 PM Technical And Device Adjustments For Endograft Treatment Of True And False Lumen Problems In Complex Aortic Dissections: How To Prevent Strokes
  Presenters: Geoffrey H. White, M.D.  
5:23 PM - 5:30 PM Is Embolic Protection Necessary For Renal Stenting: How Should It Be Done And When Can’t It Be Done?
  Presenters: Jon G. Moss, M.D.  
5:31 PM - 5:40 PM Panel Discussion
END OF SESSION XVI
 
SESSION XVII SCHEDULE
Thursday
SESSION XVII: UPDATES AND NEW CONCEPTS IN VASCULAR DISEASE AND ITS TREATMENT (7-MINUTE TALKS)
Moderators:Juan C. Parodi, M.D.
x
5:40 PM - 5:47 PM The Truth About The Thrombosis Problem With Drug Eluting Stents In The Coronary Circulation: It’s Not As Bad As We Have Been Led To Believe
  Presenters: Gregg W. Stone, M.D.  
5:47 PM - 5:54 PM The Truth About The Drawbacks Of Drug Eluting Stents: It’s Worse Than We Have Been Led To Believe
  Presenters: Renu Virmani, M.D.  
5:55 PM - 6:02 PM Where Are We Going With Drug Eluting Stents: How Much Better Will They Get: Will Coronary Stenting Increase Or Decrease?
  Presenters: Martin B. Leon, M.D.  
6:03 PM - 6:10 PM New Horizons In Imaging And Remote Guidance Of Catheter And Guidewire Tips And Stiffness: How Will These Make A Difference?
  Presenters: Alan B. Lumsden, M.D., F.A.C.S. / William Hendren, M.D.  
6:11 PM - 6:18 PM Experience With Stent Grafts (Viabahn) In The Treatment Of Superficial Femoral Artery Occlusions And Popliteal Aneurysms
  Presenters: Giovanni P. Deriu, M.D.  
6:19 PM - 6:26 PM Really Long-Term Follow-up (10 Years) Of Iliac And Aortic Stents And Kissing Stents
  Presenters: Götz M. Richter, M.D., Ph.D.  
6:27 PM - 6:34 PM CO2 As A Contrast Agent For EVAR: Technique, Advantages And Limitations
  Presenters: Fred A. Weaver, M.D.  
6:35 PM - 6:42 PM New Developments In Oral Anticoagulants: Will Heparin And Coumadin Be Replaced And Why?
  Presenters: William M. Stone, M.D. / Samuel R. Money, M.D., M.B.A.  
6:43 PM - 6:53 PM Panel Discussion
END OF SESSION XVII
 
SESSION XVIII SCHEDULE
Thursday
SESSION XVIII: ISVS AWARD PAPERS (8-MINUTE TALKS)
Moderators:Peter R.F. Bell, M.D., F.R.C.S., D.S.C., K.B.E. / Rajiv Parakh, M.B.B.S., M.S., F.R.C.S.
x
6:53 PM - 7:01 PM A Prospective Clinical, Economic And Quality Of Life Analysis Of Open Repair (OR), Endovascular Repair (EVAR) And Best Medical Treatment (BMT) In High-Risk Patients With Abdominal Aortic Aneurysms (AAA) Suitable For EVAR: The Irish Patient Trial
  Presenters: Sherif Sultan, M.D.  
7:02 PM - 7:10 PM Perioperative Microemboli And Platelet Aggregation In Patients Undergoing Carotid Endarterectomy
  Presenters: Thijs J.M. Vogten, M.D., Ph.D.  
7:11 PM - 7:19 PM Reliability Of Aortic Diameters In Patients With Hypovolemic Shock: A Challenge For Endograft Sizing
  Presenters: Joffrey van Prehn, M.D.  
7:20 PM - 7:28 PM The Effect Of Blood Pressure On Aneurysm Size In The Presence Of A Type II Endoleak
  Presenters: Jade S. Hiramoto, M.D.  
7:29 PM - 7:35 PM Panel Discussion
END OF SESSION XVIII